SC Johnson Professional Launches New Healthcare Website

SC Johnson Professional has launched a new website for its healthcare portfolio, SC Johnson Professional Healthcare products contribute to helping to slow the spread of infection within health care facilities, by implementing safety protocols that...

Hologic Debuts Documentary-Style Film Highlighting One Woman’s Breast Cancer Journey Timed to Breast Reconstruction Awareness Day

Global leader in women’s health partners with medical streaming platform, Mediflix, to provide first-of-its-kind awareness and education tool highlighting reconstructive options for breast cancer patients In conjunction with ongoing Breast Cancer Awareness Month...

New Preoperative Surgical Planning Product for Total Hip Arthroplasty

Intellijoint Surgical has announced a new preoperative surgical planning product for total hip arthroplasty. Intellijoint VIEW is a surgical planning software that provides targets for functional cup position accounting for hip-spine relationship and implant...

Fujifilm Launches First FDA Cleared Dual-Channel Endoscope for Upper and Lower Gastrointestinal Applications

Fujifilm will showcase its El-740D/S dual-channel endoscope at the American College of Gastroenterology convention in Las Vegas, October 22-27 FUJIFILM Healthcare Americas Corporation, a provider of endoscopic imaging and endosurgical solutions, has announced the...

Stryker Launches New Tendon Fixation Device System

Stryker Citrelock

Stryker’s Trauma & Extremities division has launched its Citrelock Tendon Fixation Device System. The new system provides surgeons a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, that has unique chemical and mechanical properties for orthopaedic surgical applications. Stryker will debut Citrelock at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting, Sept. 22-25, 2021, in Charlotte, N.C.

“Our customers are looking for a more predictable and effective bioresorbable material than what is currently on the market,” said Michael Rankin, VP Marketing and Medical Education, Stryker Foot & Ankle. “The Citrelock Tendon Fixation Device System helps fill that need with its innovative material technology and unique design. Citregen is an exciting addition to Stryker’s existing biomaterial portfolio and will be expanded for use in additional Stryker Trauma & Extremities indications in the future.”

The Citrelock Tendon Fixation Device System offers surgeons:

  • A controlled and homogeneous resorption process that prevents bulk degradation and chronic inflammation.[1]
  • Compressive strength that is comparable to cortical bone with a modulus comparable to cancellous bone.[1,2]
  • Citregen contains citrate, calcium, and phosphate molecules that are inherent to the bone anatomy.[1]
  • Material polymer structure that mimics the extracellular matrix protein network.[1]
  • Citregen maintains structural integrity during the healing phase, while the implant is replaced by host tissue over time.[1]

“By leveraging Citregen’s unique material properties, the Citrelock Tendon Fixation Device System introduces design features to ease insertion and secure fixation without damaging the tendon during placement,” said Wayne Berberian, MD, orthopaedic surgeon at HMH Hackensack University Medical Center. “It has been exciting to observe the development of a biomaterial for use in orthopaedic applications. I’m excited to start using Citrelock in my practice.”

Citrelock will be featured during one of Stryker’s industry sessions at AOFAS on September 24. The company is also hosting a new product reception highlighting the benefits of Citrelock along with other recent additions to its Foot & Ankle portfolio. For more information, visit or stop by the Stryker booth (No. 425).



Submit a Comment

Your email address will not be published. Required fields are marked *